Product Information

MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by AvPAK, priced at $0.0765 per EA under NDC 50268056115. Its NADAC has been published 365 times since Nov 27, 2019.

FDA first approved this application on Sep 12, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIDODRINE HCL 2.5 MG TABLET

Midodrine Hydrochloride
$0.0765per EA

Strength

2.5 mg/1

Manufacturer

AvPAK

NDC

50268056115

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MIDODRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077746

FDA Approved

9/12/2006

TE Code

AB

On Market Since

8/26/2019

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 365 times since Nov 27, 2019, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0765 per EA
All-time high$0.4071 (Apr 15, 2020)
All-time low$0.0668 (Nov 20, 2024)
52-week high$0.0773
52-week low$0.0703
Median price$0.1741
Average price$0.1677
Largest weekly change+59.2% (Nov 22, 2023)
Weeks tracked365
Tracking sinceNov 27, 2019

Price History

1W

-1.0%

1M

+3.9%

3M

+5.1%

6M

+3.5%

1Y

+6.4%

3Y

-31.6%

5Y

-68.8%

All

-77.3%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by AvPAK, is $0.0765 per EA (NDC 50268056115), effective Nov 18, 2026.

How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 77.3%. It has been tracked across 365 weekly CMS publications since Nov 27, 2019.

What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?

Since Nov 27, 2019, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.4071 (Apr 15, 2020), with a median of $0.1741 per EA.

Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIDODRINE HCL 2.5 MG TABLET?

MIDODRINE HCL 2.5 MG TABLET (NDC 50268056115) is labeled by AvPAK, and CMS classifies it as a generic product.